Insights into the mechanisms leading to progression from MGUS and SMM to multiple myeloma Published 2022-10-13 Download video MP4 360p Recommendations 09:25 MGUS diagnosis: a step-by-step approach 05:30 Changing perceptions of MGUS progression: explaining the data 04:18 Why is knowing your free light chain ratio important? 05:56 Multiple Myeloma and Bence Jones Proteins 03:47 what is MGUS? Is it cancer? How many people have MGUS, and how long can I have it? 11:35 What is Monoclonal gammopathy of undetermined significance (MGUS)? | NCLEX-RN | Khan Academy 49:36 Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention 1:21:29 Sauna Benefits Deep Dive and Optimal Use with Dr. Rhonda Patrick & MedCram 03:15 What is the best diet for myeloma patients to build a strong immune system? 21:56 Monoclonal Gammopathies: What you need to know 04:14 Understanding MGUS, Smoldering and Multiple Myeloma 03:33 The Role of Lifestyle on MGUS Progression | Betsy O’Donnell, MD | ASCO 2023 03:21 What are light chains, how are light chains reported, and why? 08:07 MGUS with Multiple Paraproteins: Results from the Population-Based iStopMM Screening Study 11:41 Multiple Myeloma - signs and symptoms, pathophysiology, treatment 03:20 MGUS and neuropathy: current understanding and unmet needs 04:37 Multiple Myeloma Precursor Conditions | High Impact Topic (HIT) 02:19 MGUS: predicting the risk of progression 02:59 What is MGUS? 10:11 What is multiple myeloma? | Hematologic System Diseases | NCLEX-RN | Khan Academy Similar videos 01:26 Determining the prevalence of MGUS & deciphering the mechanisms of disease progression 03:04 Identifying high-risk patients with SMM & MGUS to prevent progression to active myeloma 01:53 An insight into the heterogeneity of SMM and how genetic subtypes impact risk of disease progression 02:31 Defining precursor conditions in multiple myeloma & strategies to better predict risk of progression 05:07 Should individuals dx with MGUS or SMM be receiving bisphosphonates? 00:41 Improving risk stratification models for patients with MGUS and smoldering myeloma 02:15 Myeloma Canada InfoVideo Series #31 - MGUS and Smoldering Multiple Myeloma 35:13 Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of Action 05:04 The PANGEA model: improving risk stratification in multiple myeloma 22:44 How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar 59:58 Epidemiology of Multiple Myeloma and Related Precursor States - A Model for Early Detection 02:35 Using single-cell RNA-sequencing to identify biomarkers of progression in patients with SMM 02:01 Redefining MGUS to better predict progression to active disease 00:56 How do we define smoldering multiple myeloma? 02:42 The importance of better identifying individuals with MGUS & the possibility of treating precursors More results